Published in J Am Coll Cardiol on October 30, 2007
Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase. Breast Cancer Res (2011) 1.15
Junctional adhesion molecule-C is a soluble mediator of angiogenesis. J Immunol (2010) 1.00
Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One (2010) 1.00
Inhibition of junctional adhesion molecule-A/LFA interaction attenuates leukocyte trafficking and inflammation in brain ischemia/reperfusion injury. Neurobiol Dis (2014) 0.89
Prevalence of subclinical atherosclerosis is increased in systemic sclerosis and is associated with serum proteins: a cross-sectional, controlled study of carotid ultrasound. Rheumatology (Oxford) (2013) 0.87
Predicting candidate genes based on combined network topological features: a case study in coronary artery disease. PLoS One (2012) 0.83
Junctional adhesion molecule-A is abnormally expressed in diffuse cutaneous systemic sclerosis skin and mediates myeloid cell adhesion. Ann Rheum Dis (2010) 0.82
Transcription and translation of human F11R gene are required for an initial step of atherogenesis induced by inflammatory cytokines. J Transl Med (2011) 0.81
Early Detection of Junctional Adhesion Molecule-1 (JAM-1) in the Circulation after Experimental and Clinical Polytrauma. Mediators Inflamm (2015) 0.77
The perioperative time course and clinical significance of the chemokine CXCL16 in patients undergoing cardiac surgery. J Cell Mol Med (2015) 0.77
Immunological aspects of atherosclerosis. Semin Immunopathol (2013) 0.77
Endothelial Cell Junctional Adhesion Molecules: Role and Regulation of Expression in Inflammation. Arterioscler Thromb Vasc Biol (2016) 0.77
Emerging paradigms, platforms, and unifying themes in biomarker science. J Am Coll Cardiol (2007) 0.76
APOC3 induces endothelial dysfunction through TNF-α and JAM-1. Lipids Health Dis (2016) 0.75
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation (2004) 23.07
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol (2004) 6.50
Angiogenic Gene Therapy (AGENT) trial in patients with stable angina pectoris. Circulation (2002) 2.60
Plasma interleukin-10 levels and adverse outcomes in acute coronary syndrome. Am J Med (2011) 2.59
Adiponectin is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction in patients presenting with chest pain. Eur Heart J (2006) 2.47
Comprehensive gene expression profiles reveal pathways related to the pathogenesis of chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A (2004) 2.42
Impact of completeness of percutaneous coronary intervention revascularization on long-term outcomes in the stent era. Circulation (2006) 2.29
Results of the National Cholesterol Education (NCEP) Program Evaluation ProjecT Utilizing Novel E-Technology (NEPTUNE) II survey and implications for treatment under the recent NCEP Writing Group recommendations. Am J Cardiol (2005) 2.11
Changes in QT dispersion after thrombolysis for stroke. Int J Cardiol (2007) 2.08
Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation (2005) 2.03
Relation between red blood cell distribution width (RDW) and all-cause mortality at two years in an unselected population referred for coronary angiography. Int J Cardiol (2009) 2.02
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
A risk score to predict in-hospital mortality for percutaneous coronary interventions. J Am Coll Cardiol (2006) 1.84
Triggers of hospitalization for venous thromboembolism. Circulation (2012) 1.76
Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol (2005) 1.71
Debate: CON Position. Formal assessment of donor kidney function should be mandatory. Am J Nephrol (2011) 1.71
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Arterioscler Thromb Vasc Biol (2004) 1.70
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. Circulation (2005) 1.67
Frequency of swing-segment stenosis in referred dialysis patients with angiographically documented lesions. Am J Kidney Dis (2008) 1.66
Complement component C3 mediates inflammatory injury following focal cerebral ischemia. Circ Res (2006) 1.63
Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2010) 1.58
Lung resident mesenchymal stem cells isolated from human lung allografts inhibit T cell proliferation via a soluble mediator. J Immunol (2008) 1.42
Timing of nitric oxide donor supplementation determines endothelin-1 regulation and quality of lung preservation for transplantation. Am J Respir Cell Mol Biol (2002) 1.41
Impact of gender on in-hospital percutaneous coronary interventional outcomes in African-Americans. J Invasive Cardiol (2007) 1.39
Do clinicians know which of their patients have central venous catheters?: a multicenter observational study. Ann Intern Med (2014) 1.39
Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components. J Clin Sleep Med (2008) 1.38
Role of CD39 (NTPDase-1) in thromboregulation, cerebroprotection, and cardioprotection. Semin Thromb Hemost (2005) 1.32
Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndrome. Am J Cardiol (2007) 1.32
Tissue inhibitor of metalloproteinase-1 (TIMP-1) is an independent predictor of all-cause mortality, cardiac mortality, and myocardial infarction. Am Heart J (2006) 1.31
Brain injury and neurofunctional deficit in neonatal mice with hypoxic-ischemic encephalopathy. Behav Brain Res (2003) 1.31
F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: role in inflammatory thrombosis. Thromb Haemost (2002) 1.29
Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther (2003) 1.29
Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J (2006) 1.24
Association of a polymorphism in the P2X7 gene with tuberculosis in a Gambian population. J Infect Dis (2002) 1.23
Self-regulation of inflammatory cell trafficking in mice by the leukocyte surface apyrase CD39. J Clin Invest (2009) 1.22
Ethnic differences in electrocardiographic criteria for left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint. Am J Hypertens (2002) 1.21
The Metabolic Syndrome in African Americans: a review. Ethn Dis (2003) 1.20
The role of social media in online weight management: systematic review. J Med Internet Res (2013) 1.18
Endothelial response to hypoxia: physiologic adaptation and pathologic dysfunction. Curr Opin Crit Care (2002) 1.16
Prevalence and associations of anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004. Am J Kidney Dis (2008) 1.16
Health care cost and value: the way forward. JAMA (2012) 1.15
Carbon monoxide rescues ischemic lungs by interrupting MAPK-driven expression of early growth response 1 gene and its downstream target genes. Proc Natl Acad Sci U S A (2006) 1.14
Substitution profile of Delta9-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta9-tetrahydrocannabinol. Psychopharmacology (Berl) (2008) 1.13
Red cell distribution width (RDW) as a predictor of long-term mortality in patients undergoing percutaneous coronary intervention. Thromb Haemost (2009) 1.13
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) activation suppresses ischemic induction of Egr-1 and its inflammatory gene targets. FASEB J (2002) 1.13
Induction of DNA polymerase beta-dependent base excision repair in response to oxidative stress in vivo. Carcinogenesis (2002) 1.13
cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J Biol Chem (2010) 1.11
Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. Am J Pathol (2006) 1.11
Late measures of brain injury after neonatal hypoxia-ischemia in mice. Stroke (2004) 1.10
Targeting therapeutics to the vascular wall in atherosclerosis--carrier size matters. Atherosclerosis (2011) 1.09
COX inhibitors and thromboregulation. N Engl J Med (2002) 1.08
Attenuation of DNA polymerase beta-dependent base excision repair and increased DMS-induced mutagenicity in aged mice. Mutat Res (2002) 1.07
Heterotopic vascularized murine cardiac transplantation to study graft arteriopathy. Nat Protoc (2007) 1.02
Prognostic implications of normal (<0.10 ng/ml) and borderline (0.10 to 1.49 ng/ml) troponin elevation levels in critically ill patients without acute coronary syndrome. Am J Cardiol (2008) 1.01
Ecto-5' nucleotidase (CD73)-mediated adenosine generation and signaling in murine cardiac allograft vasculopathy. Circ Res (2008) 1.01
Low plasma RANTES levels are an independent predictor of cardiac mortality in patients referred for coronary angiography. Arterioscler Thromb Vasc Biol (2007) 1.01
Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis (2009) 0.98
Epithelial interactions and local engraftment of lung-resident mesenchymal stem cells. Am J Respir Cell Mol Biol (2011) 0.98
Suppression of murine cardiac allograft arteriopathy by long-term blockade of CD40-CD154 interactions. Circulation (2002) 0.98
PKCbeta regulates ischemia/reperfusion injury in the lung. J Clin Invest (2004) 0.98
Caloric restriction promotes genomic stability by induction of base excision repair and reversal of its age-related decline. DNA Repair (Amst) (2003) 0.97
Early growth response 1 mediates the systemic and hepatic inflammatory response initiated by hemorrhagic shock. Shock (2007) 0.96
Neuronal RAGE expression modulates severity of injury following transient focal cerebral ischemia. J Clin Neurosci (2008) 0.96